 Excitation-contraction coupling, Ca 2+ and Na + regulation in the normal and diseased heart;  Cellular bases of triggered ventricular arrhythmias Research.

Slides:



Advertisements
Similar presentations
Genesis of Cardiac Arrhythmias Mike Hansen Biology Department Eastern CT State University.
Advertisements

Calcium Homeostasis and Signaling in Yeast Cells and Cardiac Myocytes Jiangiun Cui, J.A. Kaandorp, P.M.A. Sloot Section Computational Science University.
Stefano Severi C 3 MIG 7 maggio Introduzione It is well known that changes in serum calcium influence the cardiac electrical activity particularly.
Homozygous mice that lack the proline-alanine rich region and C1 domain of cMyBP-C (p/a-C1 -/- mice, Figure 1) were developed by Witt et al.. 4 Figure.
Disregulation of Akt Associated with Enhanced Cardiotoxicity in ß2-Adrenergic Receptor (AR) Knockout Mice: Possible Mechanism of Crosstalk Between ß-Receptors.
Ca Na H 2Na H Cyt ATP Sarcolemma I Ca Ca 3Na SR RyR 3Na Ca T-Tubule Na Ca NCX ATP 2K ATP PLB AP (E m ) [Ca] i Contraction 3Na 2K ATP by D.M. Bers.
objectives Overview of the cardiovascular system Cardiac muscle and the heart The heart as a pump Excitation-contraction coupling and relaxation in cardiac.
Examining the Science Underlying Myocardial Ischemia.
Gene annotation for heart rhythm 1.Control of heart rate 2.Action Potential 3.Ion channels and transporters 4.Arrhythmia 5.EC coupling.
Cardiovascular Physiology
7 Feb 05 Part II1 PHARMACOLOGY 545 Cardiovascular Pharmacology Cardiac SL ion transport systems Part II 7 February 2005.
Dr. Mona Soliman, MBBS, MSc, PhD Associate Professor Department of Physiology Chair of Cardiovascular Block College of Medicine King Saud University.
Differential regulation of calcium regulatory proteins between sevoflurane postconditioning and delayed remote ischemic preconditioning in an isolated.
INTRACELLULAR CALCIUM RELEASE IN NORMAL AND DISEASED HEART Sandor Gyorke DHLRI, 507.
CT-1 Mechanistic Evaluation of the Effects of Ranolazine on Ventricular Repolarization Luiz Belardinelli, MD VP, Drug Research and Pharmacological Sciences.
András Varró Department of Pharmacology and Pharmacotherapy University of Szeged, Hungary Albert Szent-Györgyi Medical Center 2006 CALCIUM HANDLING AND.
Diabetes and Myocardial Ischaemia - Sensitivity of the diabetic heart to ischemic injury.
Joshua T. Maxwell, Timothy L. Domeier*, and Lothar A. Blatter β-adrenergic Stimulation Increases the Intra-SR Ca Termination Threshold for Spontaneous.
Beta Adrenergic Signaling in Heart Roles of local signaling complexes.
The Myofilament Ca 2+ Sensitizer Levosimendan Preserves Systolic Function in Rats with Volume Overload Heart Failure Kristin Lewis, DVM Pathology Resident/Graduate.
Effect of mechanical factors on rhythm disturbances in mathematical model of cardiac fiber 30/10/ Alexander Kursanov, L.B. Katsnelson, N.A. Vikulova,
Calcium Cycling in Cardiac Cells
Tomaselli Lab Department of Medicine Division of Cardiology Ross 844 GFP-LC3 Cx43 MERGE 5 mm WTIQ/AA 1 sec 0 WT IQ/AA IQ/AA + Ranol.
Role of microRNAs in heart diseases
Differences in cardiac atrial and ventricular ion channels Norbert Jost, PhD Department of Pharmacology & Pharmacotherapy, University of Szeged Division.
Mechanisms of Myocardial Contraction Dr. B. Tuana.
Regulation of intracellular Ca 2+ -release channels by Ca 2+ and Ca 2+ -binding proteins Nael Nadif Kasri September 21st, 2004.
Excitation-contraction coupling and drugs W. Rose.
Regulation of Ion Channels by Drugs and Hormones Roles of local signaling complexes Lessons from Investigation of Human Disease Pharmacology Unique to.
Donna H. Korzick, Ph.D. Noll Physiological Research Center and The Department of Kinesiology Regulation of Cardiac EC-Coupling: A Cellular Update Experimental.
Dysfunctional Sarcoplasmic Reticulum Ca 2+ Release Underlies Arrhythmogenic Triggers in Catecholaminergic Polymorphic Ventricular Tachycardia: A Simulation.
Models of Myocyte Excitation- Contraction Coupling.
Cardiac excitation-contraction coupling and its regulation by positive inotropic drugs. The cardiac cycle is initiated by membrane depolarization, which.
Figure 5 Effect of concomitant PDE3 and PDE4 inhibition on SR Ca2+ load and fractional release in ARVMs. (A) Representative traces of Ca2+
Molecular Determinants of Na+ and K+ Channel Regulation in Heart: Ion Channels as Targets of Neurohormones and Drugs.
Cyclic nucleotide signalling in cardiac myocytes and its relation to contraction and arrhythmias. Cyclic nucleotide signalling in cardiac myocytes and.
Parvalbumin Corrects Slowed Relaxation in Adult Cardiac Myocytes Expressing Hypertrophic Cardiomyopathy-Linked α-Tropomyosin Mutations by Pierre Coutu,
Neuroscience Fundamentals 112C Ian Parker
Volume 99, Issue 3, Pages (October 1999)
Gene expression, LTP, ion channels, enzymes, cell death
Stress Pathways and Heart Failure
The Genetic Basis for Cardiomyopathy
Diastolic heart failure in anaesthesia and critical care
Volume 11, Issue 1, Pages (January 2014)
Volume 14, Issue 1, Pages (January 2017)
K May 03 03/05/23 1.
C. Allyson Walker, BA, Fred A. Crawford, MD, Francis G
Volume 98, Issue 10, Pages (May 2010)
Volume 99, Issue 3, Pages (August 2010)
Volume 10, Issue 1, Pages (January 2013)
Elisa Bovo, Stefan R. Mazurek, Pieter P. de Tombe, Aleksey V. Zima 
Partial Inhibition of Sarcoplasmic Reticulum Ca Release Evokes Long-Lasting Ca Release Events in Ventricular Myocytes: Role of Luminal Ca in Termination.
Nat. Rev. Cardiol. doi: /nrcardio
K May 03 03/05/21 1.
Altered Myocardial Calcium Cycling and Energetics in Heart Failure—A Rational Approach for Disease Treatment  Przemek A. Gorski, Delaine K. Ceholski,
R14del-PLN in Cardiac Function
Volume 6, Issue 8, Pages (August 1996)
Edmund J. Crampin, Nicolas P. Smith  Biophysical Journal 
Hironori Hara et al. BTS 2018;3:
Partial Inhibition of Sarcoplasmic Reticulum Ca Release Evokes Long-Lasting Ca Release Events in Ventricular Myocytes: Role of Luminal Ca in Termination.
Sodium Accumulation in SERCA Knockout-Induced Heart Failure
Volume 87, Issue 5, Pages (November 2004)
Introduction Alternans is a risk factor for cardiac arrhythmia, including atrial fibrillation. At the cellular level alternans manifests as beat-to-beat.
Action potential shortening prevents atrial calcium alternans
Introduction Alternans is a risk factor for cardiac arrhythmia, including atrial fibrillation. At the cellular level alternans manifests as beat-to-beat.
Introduction Alternans is a risk factor for cardiac arrhythmia, including atrial fibrillation. At the cellular level alternans manifests as beat-to-beat.
Synergy between CaMKII Substrates and β-Adrenergic Signaling in Regulation of Cardiac Myocyte Ca2+ Handling  Anthony R. Soltis, Jeffrey J. Saucerman 
Assessment of Sarcoplasmic Reticulum Ca2+ Depletion During Spontaneous Ca2+ Waves in Isolated Permeabilized Rabbit Ventricular Cardiomyocytes  N. MacQuaide,
Volume 10, Issue 15, Pages (August 2000)
Volume 112, Issue 9, Pages (May 2017)
Presentation transcript:

 Excitation-contraction coupling, Ca 2+ and Na + regulation in the normal and diseased heart;  Cellular bases of triggered ventricular arrhythmias Research Interest Sanda Despa, PhD Department of Pharmacology

Cardiac excitation-contraction coupling Sarcolemma Ca T-Tubule Ca 3Na NCX ATP Na 3Na 2K PLM ATP I Ca Ca SR PLB ATP RyR 3Na Ca NCX

Cardiac excitation-contraction coupling Sarcolemma Ca T-Tubule Ca 3Na NCX ATP Na 3Na 2K PLM ATP I Ca Ca SR PLB ATP RyR 3Na Ca NCX

Sarcolemma Ca T-Tubule Ca 3Na NCX ATP Na 3Na 2K PLM ATP I Ca Ca SR PLB ATP RyR 3Na Ca NCX Contraction of the heart

Relaxation of the heart Sarcolemma Ca T-Tubule Ca ATP Na 3Na 2K PLM ATP I Ca Ca SR PLB ATP RyR 3Na Ca NCX 3Na NCX

Ca 2+ and contraction-relaxation of a cardiac myocyte Rat ventricular myocyte loaded with a Ca 2+ -sensitive fluorescent indicator

Project 1: Ca dysregulation and arrhythmias induced by loss-of-function of ankyrin B Ankyrin-B = multivalent “adaptor” protein that targets select membrane proteins to the cytoskeleton

Ankyrin-B loss of function mutations lead to long QT4 syndrome and ventricular arrhythmias in humans Ventricular arrhythmias E1425G mutation Long QT4 syndrome DII DIII (Schott JJ et al., Am. J. Hum. Genet. 1994) 1 sec Q-T *** QTc= 450 ms in symptomatic patients (normal QTc<420 ms in men; <440 ms in women) Long QT syndromes in humans 1 sec

Decreased NCX and NKA expression, particularly at the T-tubules, in AnkB+/- myocytes (Mohler et al., Nature 2003) AnkB+/- mice = mice heterozygous for a null mutation in ankyrin-B gene.

Caffeine Reduced NCX and NKA function in AnkB+/- myocytes NCX function NKA function Camors, …, Despa. JMCC, 2012

Similar [Na] i and diastolic [Ca] i in myocytes from AnkB+/- and WT mice [Na] i Diastolic [Ca] i RestingPacing Camors, …, Despa. JMCC, 2012

Larger Ca transients, SR Ca load & fractional release in AnkB+/- mice Camors, …, Despa. JMCC, 2012

Enhanced Ca spark frequency in intact AnkB+/- mice 200 ms 10 µm µm AnkB+/- 0 Na/ 0 Ca Tyrode 1 mM Ca Tyrode Caffeine WT Caffeine 1 s Camors, …, Despa. JMCC, 2012

More pro-arrhythmic Ca waves in AnkB+/- myocytes 20 % 60 % 10 % Control conditionISO (1 µM) AnkB+/- Camors, …, Despa. JMCC, 2012

WTAnkB+/- T-tubule NKA-α1 Cleft Ca Na Ca NCX K NKA-  2 Ca ATP Ca RyR diastolic Ca B56  Nuclear envelope IP 3 R AnkB Cleft [Ca]  T-tubule Ca ATP Ca RyR diastolic Ca Nuclear envelope P 1.What causes the increased propensity for Ca sparks and waves in AnkB+/- myocytes?  Altered cytosolic RyR regulation? Work in progress; Questions:

2. Does AnkB proteolysis by calpain lead to a cardiac phenotype similar to that caused by genetic AnkB loss-of-function? AnkB protein but not mRNA is reduced in the infarct border zone after MI Hundt et al., Cardiovasc Res. 2009;81:742 Protein expression mRNA level

Work in progress; Questions: 2. Does AnkB proteolysis by calpain lead to a cardiac phenotype similar to that caused by genetic AnkB loss-of-function? AnkB & NKA protein expression are reduced following ischemia/reperfusion; the effect is prevented by calpain inhibition Inserte et al., Circ Res 2005;97:465. NKA  How does calpain activation affect the protein expression, subcellular distribution and function of AnkB, NCX and NKA?  What is the role of AnkB proteolysis by calpain in the structural and electrical remodeling of the heart following ischemia/reperfusion?

 How is Ca cycling altered in diabetic heart disease? Timeline!  Is [Na] i altered in diabetic heart disease? Does this further alter the cardiac metabolism?  ROS production →  slowly inactivating I Na →  [Na] i →  [Ca] m →  ATP  Electrical remodeling & occurrence of arrhythmias in diabetic hearts Long QT Project 2: Electrical remodeling and arrhythmias in diabetic heart disease Pre-diabetic stage Diabetic stage

Acknowledgments University of California Davis Emmanuel Camors Kevin Voelker Florin Despa Samuel Galice Jeffrey Elliot Kaleena Jackson Brian Koch Donald M. Bers Kenneth Ginsburg Khana Dao Ohio State University Peter Mohler University of California Los Angeles Enrico Stefani Yong Wu University of Cincinnati Jerry B. Lingrel University of Manchester Fabian Brette Funding from NIH & AHA